icn pharmaceutical lticn seek acquisition icn pharmaceutical 500 mln dlrs cash 150 billion dlrs credit intend buy pharmaceutical company chairman milan panic say companys annual meeting acquisition place 24 month the company billion dlrs acquisition today panic say add we investigate number company company study possibly acquire friendly basis say panic intend seek board approval today repurchase mln icn common share discuss possibility acquisition panic purchase icns current marketing capability sufficient support distribution company product icns expectation market growth worldwide icns principal product ribavirin virazole drug market number country broadbase antiviral company application include treatment type hepatitis herpe influenza childhood disease hemorrhagic fever icn focus consirable investor attention recent month virazole undergone clinical trial treatment aidsrelate disease panic today discuss drug regard aids food drug administration complete review datum submit company investigation drug conduct house subcommittee continue subcommittee fda acknowledge conduct separate investigation determine icn witheld data fda adverse reaction drug virazole approve marketing we aerosol form treatment infection strike infant call respiratory syncytial virus